UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin : implications for Alzheimer's disease

Journal of Neural Transmission, 2000-01, Vol.107 (2), p.203-231

2000

Volltextzugriff (PDF)

Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias

Brain pathology (Zurich, Switzerland), 2006-01, Vol.16 (1), p.71-79

2006

Volltextzugriff (PDF)

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro

The American journal of pathology, 1994-11, Vol.145 (5), p.1030-1035

1994

Volltextzugriff (PDF)

Chromosome 13 dementias

Cellular and molecular life sciences : CMLS, 2005-08, Vol.62 (16), p.1814-1825

2005

Volltextzugriff (PDF)

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

The Journal of clinical investigation, 1998-08, Vol.102 (4), p.734-743

1998

Volltextzugriff (PDF)

Glycoprotein 330/Megalin: Probable Role in Receptor-Mediated Transport of Apolipoprotein J Alone and in a Complex with Alzheimer Disease Amyloid β at the Blood-Brain and Blood-Cerebrospinal Fluid Barriers

Proceedings of the National Academy of Sciences - PNAS, 1996-04, Vol.93 (9), p.4229-4234

1996

Volltextzugriff (PDF)

Amyloid Ion Channels: A Common Structural Link for Protein-Misfolding Disease

Proceedings of the National Academy of Sciences - PNAS, 2005-07, Vol.102 (30), p.10427-10432

2005

Volltextzugriff (PDF)

Substitution at codon 22 reduces clearance of Alzheimer’s amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

Neurobiology of aging, 2002-05, Vol.23 (3), p.405-412

2002

Volltextzugriff (PDF)

Vascular Variant of Prion Protein Cerebral Amyloidosis with τ -Positive Neurofibrillary Tangles: The Phenotype of the Stop Codon 145 Mutation in PRNP

Proceedings of the National Academy of Sciences - PNAS, 1996-01, Vol.93 (2), p.744-748

1996

Volltextzugriff (PDF)

Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia

Journal of Alzheimer's disease, 2001-02, Vol.3 (1), p.65-73

2001

Volltextzugriff (PDF)

Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease

Neuropathology and applied neurobiology, 2008-10, Vol.34 (5), p.492-505

2008

Volltextzugriff (PDF)

Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study

Neuropathology and applied neurobiology, 2006-10, Vol.32 (5), p.492-504

2006

Volltextzugriff (PDF)

Amyloidosis and Alzheimer’s disease

Advanced drug delivery reviews, 2002-12, Vol.54 (12), p.1539-1551

2002

Volltextzugriff (PDF)

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E

Biochemical journal, 1995-03, Vol.306 ( Pt 2) (2), p.599-604

1995

Volltextzugriff (PDF)

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

Biochemical journal, 1993-07, Vol.293 ( Pt 1) (1), p.27-30

1993

Volltextzugriff (PDF)

Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries

Journal of neurochemistry, 1996-08, Vol.67 (2), p.880-883

1996

Volltextzugriff (PDF)

Is Alzheimer's disease an apolipoprotein E amyloidosis?

The Lancet (British edition), 1995-04, Vol.345 (8955), p.956-958

1995

Volltextzugriff (PDF)

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Nature medicine, 2003-07, Vol.9 (7), p.907-913

2003

Volltextzugriff (PDF)

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

The Journal of clinical investigation, 2000-12, Vol.106 (12), p.1489-1499

2000

Volltextzugriff (PDF)

Alzheimer's disease and soluble Aβ

Neurobiology of aging, 1994-03, Vol.15 (2), p.143-152

1994

Volltextzugriff (PDF)

Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

The American journal of pathology, 1996-02, Vol.148 (2), p.361-366

1996

Volltextzugriff (PDF)

Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

Journal of neuropathology and experimental neurology, 2003-09, Vol.62 (9), p.885-898

2003

Volltextzugriff (PDF)

Amyloid Fibrils in Hereditary Cerebral Hemorrhage with Amyloidosis of Icelandic Type is a Variant of γ -trace Basic Protein (Cystatin C)

Proceedings of the National Academy of Sciences - PNAS, 1986-05, Vol.83 (9), p.2974-2978

1986

Volltextzugriff (PDF)

A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimerʼs disease and leads to death as early as the age of 28 years

Neuroreport, 1998-01, Vol.9 (2), p.217-221

1998

Volltextzugriff (PDF)

Platelet Microparticles as Carriers of Soluble Alzheimer's Amyloid β (sAβ)

Annals of the New York Academy of Sciences, 2002-11, Vol.977 (1), p.340-348

2002

Volltextzugriff (PDF)

1 – 25 von 525

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(498)
Mit Volltextzugriff
(444)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin : implications for Alzheimer's disease

Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias

Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro

Chromosome 13 dementias

Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer

Glycoprotein 330/Megalin: Probable Role in Receptor-Mediated Transport of Apolipoprotein J Alone and in a Complex with Alzheimer Disease Amyloid β at the Blood-Brain and Blood-Cerebrospinal Fluid Barriers

Amyloid Ion Channels: A Common Structural Link for Protein-Misfolding Disease

Substitution at codon 22 reduces clearance of Alzheimer’s amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood

Vascular Variant of Prion Protein Cerebral Amyloidosis with τ -Positive Neurofibrillary Tangles: The Phenotype of the Stop Codon 145 Mutation in PRNP

Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia

Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease

Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: a morphological study

Amyloidosis and Alzheimer’s disease

Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries

Is Alzheimer's disease an apolipoprotein E amyloidosis?

RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier

Alzheimer's disease and soluble Aβ

Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)

Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View

Amyloid Fibrils in Hereditary Cerebral Hemorrhage with Amyloidosis of Icelandic Type is a Variant of γ -trace Basic Protein (Cystatin C)

A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimerʼs disease and leads to death as early as the age of 28 years

Platelet Microparticles as Carriers of Soluble Alzheimer's Amyloid β (sAβ)

Suchergebnisse filtern